Document Detail

Defective and excessive immunities in pediatric diseases.
MedLine Citation:
PMID:  22726115     Owner:  NLM     Status:  Publisher    
Inflammatory and autoimmune diseases are classically considered as disorders arising from hyper-activation of immunity and hence are treated with drugs that suppress the lymphocyte activation and inflammation. Although this strategy has proven useful to cure symptoms, it rarely can heal the disease and long-term treatments are usually needed. Inflammatory and autoimmune diseases frequently occur also in patients with primary immune deficiency disease, proving that immune hyper-activation may paradoxically arise from defective function of immune genes. In these cases, the phenotype of hyper-activation is believed to reflect the attempts of the immune system to compensate for immune defects. Recent data suggest that similar mechanisms could be involved also in the pathogenesis of some multifactorial disorders, such as Crohns disease and systemic lupus erythematosus. Based on these considerations, novel therapies could be developed to cure severe autoimmune and inflammatory disorders, not only by aiming to hyper-activation but as well by focusing on the possible underlying immune defects.
Luigi Daniele Notarangelo; Alberto Tommasini
Related Documents :
10609875 - Effect of vitamin e on production of macrophage migration inhibitory factor (mif) by ma...
8755565 - An essential regulatory role for macrophage migration inhibitory factor in t-cell activ...
7876555 - Treponema pallidum and borrelia burgdorferi lipoproteins and synthetic lipopeptides act...
18302675 - Cellular basis of verruciform xanthoma: immunohistochemical and ultrastructural charact...
23325925 - Sirtuin deacylases: a molecular link between metabolism and immunity.
18773415 - Effects of iejimalide b, a marine macrolide, on growth and apoptosis in prostate cancer...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-6-21
Journal Detail:
Title:  Current pharmaceutical design     Volume:  -     ISSN:  1873-4286     ISO Abbreviation:  -     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-6-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9602487     Medline TA:  Curr Pharm Des     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Division of Immunology, Children's Hospital Boston, Harvard Medical School. Karp 9, 09210, 1 Blackfan Circle, Boston, MA 02115, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Mevalonate kinase deficiency: disclosing the role of mevalonate pathway modulation in inflammation.
Next Document:  NF-?B as a Target for Modulating Inflammatory Responses.